1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32 | Staff then sent a fax request to R1’s Primary Care Physician (PCP) regarding her condition. R1’s PCP then prescribed an Ivermectin 3 MG tablet to treat R1 with scabies. Per charting notes, R1 received Ivermectin 3 MG tablet to treat her scabies condition on January 25, 2025, February 5, 2025, March 8, 2025, and March 15, 2025. A prescription for Permethrin 5% cream was received from R1’s PCP on 2/5/25 by the facility. Per R1’s PCP, the Permethrin 5% cream was also prescribed to treat R1’s scabies condition. R1 received doses of Permethrin cream to treat her scabies condition on February 6, 2025, February 13, 2025, March 8, 2025, and March 15, 2025. Per the progress notes on March 14, 2025, R1’s hospice nurse confirmed that R1 had a scabies condition. An interview conducted with R1 also confirmed that staff were putting cream on their body for rashes. Seven out of seven staff interviews conducted also confirmed that R1 had a scabies condition and rashes over their body. On today’s visit, LPA was informed that R1 was transported to Fountain Valley hospital on May 8, 2025 due to her rashes condition worsening. Discharge papers from Fountain Valley Hospital revealed that R1 was being treated for scabies. LPA confirmed that the Orange County Regional Office (OCRO) did not receive a Special Incident Report (SIR) for R1’s scabies condition. Based on the evidence gathered during this investigation, the preponderance of evidence standard has been met, therefore the above allegation is found to be SUBSTANTIATED. A deficiency is being cited on the attached 9099D. An exit interview was conducted with Administrator Judith Torres. A copy of the report and Appeal Rights were provided. |